A Turkish perspective on coronary artery bypass surgery and percutaneous coronary artery intervention in chronic heart failure patients

Angiology
Guliz KozdagDilek Ural

Abstract

The impact of coronary revascularization methods (coronary artery bypass graft [CABG] surgery and stent implantation) on clinical outcome has not been determined yet in patients with systolic heart failure (SHF). We examined outcomes in patients discharged from our hospital after hospitalization for decompensated SHF. Of 637 patients with SHF (mean age, 64 ± 13 years; mean ejection fraction, 26.5% ± 9%), 402 patients (63%) had coronary artery disease (CAD) and 235 patients (37%) had no CAD; 223 patients (35%) died because of cardiovascular reasons during follow-up. Patients who had stenting alone and patients who had CABG surgery and stenting had better prognosis than patients with CAD but no revascularization procedure (P < .001 and P = .013, respectively). In the patients with SHF having CAD who had stenting and CABG surgery + stenting may have better prognosis compared with patients with CAD who had no revascularization procedure in their past.

References

Jun 27, 1985·The New England Journal of Medicine·E PassamaniT Killip
Nov 1, 1985·British Heart Journal·R W BrowerP G Hugenholtz
Jun 23, 1994·The New England Journal of Medicine·N G UrenP G Camici
Oct 8, 1997·Journal of the American College of Cardiology·B A BartC M O'Connor
Jul 17, 1998·The New England Journal of Medicine·W WijnsP G Camici
Apr 13, 2000·The New England Journal of Medicine·G M FelkerE K Kasper
May 12, 2000·Journal of the American College of Cardiology·J S GottdienerR C Boineau
Apr 13, 2001·Journal of the American College of Cardiology·R H Jones
Apr 1, 2004·The Surgical Clinics of North America·Stephen Westaby
Aug 16, 2005·Journal of the American College of Cardiology·Panithaya ChareonthaitaweeRaymond J Gibbons
Sep 13, 2006·Circulation·Mihai GheorghiadeRobert O Bonow
Jan 30, 2007·The Annals of Thoracic Surgery·Marco PocarFrancesco Donatelli
May 10, 2007·JAMA : the Journal of the American Medical Association·Paul ErneMatthias Pfisterer
Jan 4, 2008·Circulation·Paolo G CamiciOrnella E Rimoldi
Jan 17, 2009·Journal of the American College of Cardiology·James D FlahertyUNKNOWN Acute Heart Failure Syndromes International Working Group
Feb 21, 2009·The New England Journal of Medicine·Patrick W SerruysUNKNOWN SYNTAX Investigators
Jun 9, 2009·International Journal of Cardiology·Mustafa I AhmedAli Ahmed
Jun 9, 2009·The New England Journal of Medicine·UNKNOWN BARI 2D Study GroupBurton E Sobel
Nov 1, 2007·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Giuseppe Biondi ZoccaiImad Sheiban
Jun 18, 2010·International Journal of Cardiology·Mihai GheorghiadeAli Ahmed
Dec 15, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Enrico AmmiratiPaolo G Camici
Apr 6, 2011·The New England Journal of Medicine·Eric J VelazquezUNKNOWN STICH Investigators

❮ Previous
Next ❯

Citations

May 15, 2021·Journal of the American College of Cardiology·Puja B ParikhJaved Butler

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Software Mentioned

SPSS

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.